2024's first quarter has been fruitful for investors.
House Republicans on Thursday invited President Joe Biden to testify before Congress as part of their impeachment inquiry into him and his family’s business affairs. Rep. James Comer, chair of the House Oversight Committee, sent a letter to the Democratic president, inviting him to sit for a public hearing to “explain, under oath,” what involvement he had in the Biden family businesses.
Solid Biosciences is shrugging off several messy years in gene therapy development. The biotech stock has gotten a triple-digit boost.